OasisLMS

These sessions were presented as part of the Allied Professionals Forum at the 2019 HRS Scientific Sessions.  The Allied Professional Forum promotes quality education and inspire attendees to expand scientific discovery to apply it to their daily practice.

Part I
This session will review commonly seen and sometimes difficult to manage patients with syncope, wide complex tachycardia, and autonomic dysfunction. It will review ECG patterns that have been associated with increased risk for SCD. It will also give an update on best practices for remote monitoring.

Presentations:
Chair:  Erica S.. Zado, PAC, FHRS, Hospital of the Univ of Pennsylvania, EP, Philadelphia, PA
Chair: Jill L. Schaeffer, MSN, CRNP, FHRS, CEPS, CCDS, The Heart Group of Lancaster General Health/ Penn Medicine, Stevens, PA

Approaching the Patient with Syncope
James Armstrong, PAC, St. Elizabeth`s Medical Center, Boston, MA
Wide Complex Tachycardia: Differentiating VT from SVT with Aberration
Jose A. Joglar, MD, FHRS, UT Southwestern Med. Ctr. Dallas, Dallas, TX
Remote Monitoring: Best Practice
Stacy M. Poe, MS, MSN, ANP, Cleveland Clinic, Strongsville, OH
ECGs & SCD Risk: Patterns That You Need to Recognize
Stephanie Toth, ACNP, Bryn Mawr Hospital, Glen Mills, PA
Autonomic Dysfunction: Treating the Refractory Patient
Jill L. Schaeffer, MSN, CRNP, FHRS, CEPS, CCDS, The Heart Group, Stevens, PA

Part II
This session will give a review of the current EP guidelines and consensus statements as well as discuss any updates in EP pharmacologic treatments. It will also review how to streamline and transition care of AF patients from inpatient to outpatient to optimize outcomes.

Presentations 
Chair: Laurel Kay Racenet, MSN, FNP, FHRS, CEPS, CCDS, Alaska Heart and Vascular Inst, Anchorage, AK
Chair:  Erica S.. Zado, PAC, FHRS, Hospital of the University of Pennsylvania, EP, Philadelphia, PA

2019 EP Guideline and Consensus Update
Christopher X. Wong, MBBS, MPH, MS, PhD, University of Adelaide and Royal Adelaide Hospital, Adelaide, Australia
2019 EP Pharmacologic Update
Kristen B. Campbell, PharmD,. Duke University Hospital, Pharmacy, Durham, NC
AF Management: Streamlining Care to Optimize Outcomes
Jill L. Schaeffer, MSN, CRNP, FHRS, CEPS, CCDS, The Heart Group of Lancaster General Health/ Penn Medicine, Stevens, PA

Part III
This session will touch base on the basics of genetic testing for EP advanced practitioners including patient selection, test choice and interpretation. It will review the approach to EP patients regarding follow up care and restrictions. This session will help the provider to become comfortable approaching end of life discussions regarding device therapy and planning. It will also review the importance of device diagnostics to optimize patient outcomes and management.

Presentations:
Chair:  Gerilynn M.. Schott, ACNP,  Stanford Healthcare, San Francisco, CA
Chair:  Lindsay Harris, MSN, APRN,  Brigham and Women`s Hospital, Brookline, MA

Genetics for the EP Provider: Who, What Test and How to Interpret
Benjamin Helm, MS. Indiana University School of Medicine/Department Medical and Molecular Genetics, Indianapolis, IN
Device Management During End of Life: How to Start the Discussion
John M. Mandrola, MD,  Louisville Cardiology, Louisville, KY
EP Patient Restrictions: What's Necessary and What's Not
Aileen M. Ferrick, PhD, ACNP, RN, FHRS Westchester Medical Center- El, Larchmont, NY
Device Diagnostics: Tools to Optimize Patient Outcomes
Laurel Kay. Racenet, MSN, FNP, FHRS, CEPS, CCDS, Alaska Heart and Vascular Inst, Anchorage, AK

• Explain the step by step approach to evaluating a patient with syncope
• Explain key factors in differentiating wide complex tachycardias
• Discover treatment options for patients with autonomic dysfunction
• Analyze important factors in optimizing remote monitoring
• Analyze the current EP guidelines and consensus statements
• Determine updates in EP pharmacology
• Identify optimal management for patients with atrial fibrillation
• Demonstrate how to streamline inpatient and outpatient care for patients with AF
• Define the basics of genetic testing including patient selection, test choice and interpretation
• Demonstrate ways to approach patients with cardiac devices near their end of life
• Determine appropriate follow up care and restrictions for patients with arrhythmias and cardiac devices
• Explain how to use device diagnostics to optimize patient outcomes

Nurse Practitioner
Physician’s Assistant
Nurse

Erica S.. Zado, PAC, FHRS
Hospital of the Univ of Pennsylvania, EP, Philadelphia, PA

Jill L. Schaeffer, MSN, CRNP, FHRS, CEPS, CCDS
The Heart Group of Lancaster General Health/ Penn Medicine, Stevens, PA

James Armstrong, PAC
St. Elizabeth`s Medical Center, Boston, MA

Jose A. Joglar, MD, FHRS
UT Southwestern Med. Ctr. Dallas, Dallas, TX

Stacy M. Poe, MS, MSN, ANP
Cleveland Clinic, Strongsville, OH

Stephanie Toth, ACNP
Bryn Mawr Hospital, Glen Mills, PA

Jill L. Schaeffer, MSN, CRNP, FHRS, CEPS, CCDS
The Heart Group, Stevens, PA

Laurel Kay Racenet, MSN, FNP, FHRS, CEPS, CCDS
Alaska Heart and Vascular Inst, Anchorage, AK

Erica S.. Zado, PAC, FHRS
Hospital of the University of Pennsylvania, EP, Philadelphia, PA

Christopher X. Wong, MBBS, MPH, MS, PhD
University of Adelaide and Royal Adelaide Hospital, Adelaide, Australia

Kristen B. Campbell, PharmD
Duke University Hospital, Pharmacy, Durham, NC

Jill L. Schaeffer, MSN, CRNP, FHRS, CEPS, CCDS
The Heart Group of Lancaster General Health/ Penn Medicine, Stevens, PA

Gerilynn M.. Schott, ACNP
Stanford Healthcare, San Francisco, CA

Lindsay Harris, MSN, APRN
Brigham and Women`s Hospital, Brookline, MA

Benjamin Helm, MS
Indiana University School of Medicine/Department Medical and Molecular Genetics, Indianapolis, IN

John M. Mandrola, MD
Louisville Cardiology, Louisville, KY

Aileen M. Ferrick, PhD, ACNP, RN, FHRS
Westchester Medical Center- El, Larchmont, NY

Laurel Kay. Racenet, MSN, FNP, FHRS, CEPS, CCDS
Alaska Heart and Vascular Inst, Anchorage, AK

Accreditation Statement
The Heart Rhythm Society is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians AMA Designation Statement
The Heart Rhythm Society designates this internet enduring activity for a maximum of 4.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM Maintenance of Certification (MOC) Statement 

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 4.25 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Deadline to Report MOC Points to ABIM 

ABIM MOC Points: Claim your points before December 31, 2021.

Royal College of Physicians and Surgeons of Canada MOC Recognition Statement
Through an agreement between the Accreditation Council for Continuing Medical Education and the Royal College of Physicians and Surgeons of Canada, medical practitioners participating in the Royal College MOC Program may record completion of accredited activities registered under the ACCME’s “CME in Support of MOC” program in Section 3 of the Royal College’s MOC Program.

Other Credit Available
A Credit Certificate (for physicians) or Certificate of Participation (for non-physicians) will be provided to individuals seeking credit from the following organizations which accept AMA PRA Category 1 Credit(s)™. Note that participants are advised to contact their certifying body for specific information regarding credit submissions:
·         American Academy of Family Physicians (AAFP) for elective credit
·         American Academy of Nurse Practitioners Certification Board (AANPCB)
·         American Academy of Physician Assistants (AAPA)
·         American Nurses Credentialing Center (ANCC)
·         American Osteopathic Association (AOA) for Category 2 credit
·         Committee on Accreditation of Continuing Medical Education (Canada)
·         European Board for Accreditation in Cardiology (EBAC)
·         European CME Credits (ECMEC)
·         German Chambers of Physicians
·         National Society of Genetic Counselors
·         Oman Medical Specialty Board
·         Qatar Council for Healthcare Practitioners
·         Royal College of Physicians and Surgeons of Canada (RCPSC)

CME Disclosure Policy

The Heart Rhythm Society is committed to the provision of Continuing Medical Education (CME) that is balanced, objective, and evidence-based. The Heart Rhythm Society adheres to the Standards for Commercial Support (SCS) of the Accreditation Council for Continuing Medical Education (ACCME) which requires that those individuals in a position to control the content of an educational activity (including planners, faculty, authors, committee members, content reviewers, editors, and staff) disclose all relevant* financial relationships (for self and for individual's spouse/partner) with an ACCME-defined commercial interest** from the preceding 12 months.

Any individual who refuses to disclose financial relationships is disqualified from participating in HRS educational activities. Employees and Owners of ACCME-defined commercial interests may have no role in the planning or implementation of CME activities without a special exception from the HRS Chief Learning Officer that is granted only in specific circumstances that meet stringent ACCME requirements.

ACCME Definitions:

 *Relevant financial relationships are financial relationships in any amount, which occurred in the twelve-month period preceding the time that the individual was asked to assume a role controlling content of the CME activity, and which relate to the content of the educational activity, causing a conflict of interest. The ACCME considers financial relationships to create conflicts of interest in CME when individuals have both a financial relationship with a commercial interest and the opportunity to affect the content of CME about the products or services of that commercial interest.

 **A commercial interest is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. The ACCME does not consider providers of clinical service directly to patients to be commercial interests - unless the provider of clinical service is owned, or controlled by, an ACCME-defined commercial interest.

Chair Disclosures:

L.K. Racenet, MSN, FNP, FHRS, CEPS, CCDS: Nothing relevant to disclose.
G.M. Schott, ACNP:   Nothing relevant to disclose.
L. Harris, MSN, APRN: Nothing relevant to disclose. 
E.S. Zado, PAC: Nothing relevant to disclose.
J.L. Schaeffer, MSN, CRNP, FHRS, CEPS, CCDS:  Honoraria/Speaking/Consulting Fee - Abbott Laboratories.

Faculty Disclosures:
J. Armstrong, PAC: Nothing relevant to disclose.
J.A. Joglar, MD, FHRS: Nothing relevant to disclose.
S.M. Poe, MS, MSN, ANP:   Nothing relevant to disclose.
S. Toth, ACNP: Nothing relevant to disclose.
L.K. Racenet, MD: Nothing relevant to disclose.
C.X. Wong, MBBS, MPH, MS, PhD:  Nothing relevant to disclose.
K.B. Campbell, PharmD: Nothing relevant to disclose.
B. Helm, MS: Nothing relevant to disclose.
J.M. Mandrola, MD: Nothing relevant to disclose.
A.M. Ferrick, PhD, ACNP, RN, FHRS: Nothing relevant to disclose.


Reviewer Disclosures:
P. Aziz, MD: Nothing relevant to disclose
S. Cox, MD: Nothing relevant to disclose

HRS Staff Disclosures:
R. Werlinich: Nothing relevant to disclose.
Obse Debela: Nothing relevant to disclose.

The Heart Rhythm Society is committed to the provision of Continuing Medical Education (CME) that is balanced, objective, and evidence-based. The Heart Rhythm Society adheres to the Standards for Commercial Support (SCS) of the Accreditation Council for Continuing Medical Education (ACCME) which requires that those individuals in a position to control the content of an educational activity (including planners, faculty, authors, committee members, content reviewers, editors, and staff) disclose all relevant financial relationships with an ACCME-defined commercial interest within the 12 months prior to the disclosure.

The Heart Rhythm Society takes steps to assure its learners and the public that the content of certified activities is accurate and reliable. The following principles are applied to the process of validating CME content. The content is peer-reviewed to ensure the following:

Fair Balance - that content is balanced among various options available for treatment and not biased toward a particular product or manufacturer.

Patient Treatment Recommendations - that patient treatment recommendations contained in the content are evidence-based, are appropriate for the target audience, and that the patient treatment recommendations contribute to overall improvement in patient care.

Scientific Validity - that scientific studies cited in the activity conform to standards accepted by the scientific community.

Learning Objectives - that the educational content supports the learning objectives of the activity, and that the objectives stated for performance-in-practice are actionable and measurable.

Omissions - that no seminal studies, data, or best evidence are missing

CME and CoP Certificates will be awarded and available to download and print following the completion of the course and the course evaluation. Should you have any questions regarding your CME certificate, please contact CME@HRSonline.org.